These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

95 related articles for article (PubMed ID: 344090)

  • 1. A trial of trimebutine in spastic colon.
    Lüttecke K
    J Int Med Res; 1978; 6(2):86-8. PubMed ID: 344090
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A three-part controlled study of trimebutine in the treatment of irritable colon syndrome.
    Lüttecke K
    Curr Med Res Opin; 1980; 6(6):437-43. PubMed ID: 6988171
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A clinical trial of trimebutine (Mebutin) in spastic colon.
    Moshal MG; Herron M
    J Int Med Res; 1979; 7(3):231-4. PubMed ID: 456734
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Double blind trial of trimebutine in the irritable bowel syndrome.
    Fielding JF
    Ir Med J; 1980 Oct; 73(10):377-9. PubMed ID: 7000730
    [No Abstract]   [Full Text] [Related]  

  • 5. [Comparative clinical study of the combination of clidinium(br)-chlordiazepoxide and trimebutine in the treatment of functional colopathies].
    Copé R
    Med Chir Dig; 1981; 10(8):713-7. PubMed ID: 6896078
    [No Abstract]   [Full Text] [Related]  

  • 6. [A new treatment of functional colopathies: Modulite].
    Chevrel B
    Med Chir Dig; 1982; 11(2):151-4. PubMed ID: 7098595
    [No Abstract]   [Full Text] [Related]  

  • 7. [Clinical and instrumental evaluation by multiple colonic manometry of tiropramide, trimebutine and octylonium bromide in irritable colon. II. Repeated oral administration].
    Galeone M; Benazzi E; Bossi M; Moise G; Riva A; Stock F
    Pharmatherapeutica; 1986; 4(8):496-509. PubMed ID: 3714757
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Clinical and instrumental evaluation by multiple colonic manometry of tiropramide, trimebutine and octylonium bromide in the irritable colon: I. Administration by single i.v].
    Galeone M; Stock F; Moise G; Cacioli D; Benazzi E; Riva A
    Pharmatherapeutica; 1986; 4(7):445-56. PubMed ID: 3960945
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Fenoverine: a two-step, double-blind and open clinical assessments of its smooth muscle synchronizing effects.
    Bader F
    Pharmatherapeutica; 1986; 4(7):422-8. PubMed ID: 3515369
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Fenoverine: smooth muscle synchronizer for the management of gastro-intestinal conditions. II. A trimebutine-controlled, double-blind, crossover clinical evaluation.
    Camarri E
    Curr Med Res Opin; 1986; 10(1):52-7. PubMed ID: 3516580
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [The use of Debridat in treating the irritable bowel syndrome].
    Parfenov AI
    Voen Med Zh; 1996 May; 317(5):37-8. PubMed ID: 8754091
    [No Abstract]   [Full Text] [Related]  

  • 12. [Mechanism of action of trimebutine maleate on gastro-colic reflex in patients with irritable bowel syndrome].
    Matsue T; Yamato S; Umeda N
    Nihon Heikatsukin Gakkai Zasshi; 1990 Apr; 26(2):89-92. PubMed ID: 2273694
    [No Abstract]   [Full Text] [Related]  

  • 13. Trimebutine: mechanism of action, effects on gastrointestinal function and clinical results.
    Delvaux M; Wingate D
    J Int Med Res; 1997; 25(5):225-46. PubMed ID: 9364286
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Trimebutine. Pharmacology, recent concepts about its mechanism of action, therapeutic results].
    Fraitag B; Hostein J; Pascaud X; Junien JL
    Gastroenterol Clin Biol; 1992; 16(5):413-20. PubMed ID: 1526395
    [No Abstract]   [Full Text] [Related]  

  • 15. Efficacy of trimebutine therapy in patients with gastroesophageal reflux disease and irritable bowel syndrome.
    Kountouras J; Chatzopoulos D; Zavos C; Boura P; Venizelos J; Kalis A
    Hepatogastroenterology; 2002; 49(43):193-7. PubMed ID: 11941952
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Trimebutine, a new antispasmodic in the treatment of dyspepsia.
    Walters JM; Crean P; McCarthy CF
    Ir Med J; 1980 Oct; 73(10):380-1. PubMed ID: 7429788
    [No Abstract]   [Full Text] [Related]  

  • 17. Effect of trimebutine on colonic myoelectrical activity in IBS patients.
    Frexinos J; Fioramonti J; Bueno L
    Eur J Clin Pharmacol; 1985; 28(2):181-5. PubMed ID: 3987797
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Controlled evaluation of a new synthetic spasmolytic (DA 3177) in/pathology of the digestive system].
    Battocchio F; Negri L; Tacchettti G
    Clin Ter; 1979 Jun; 89(6):601-10. PubMed ID: 397029
    [No Abstract]   [Full Text] [Related]  

  • 19. Mebeverine in patients with the irritable colon syndrome: double blind study.
    Tasman-Jones C
    N Z Med J; 1973 Apr; 77(491):232-5. PubMed ID: 4581721
    [No Abstract]   [Full Text] [Related]  

  • 20. [DA 3177 a new synthetic spasmolytic agent in the management of spastic-dyskinetic conditions of the digestive tract. Double-blind controlled clinical trial].
    Bonzi G; Reguzzoni G; Rocca F; Negri L
    Clin Ter; 1979 Apr; 89(2):187-96. PubMed ID: 385213
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 5.